Neutrophil-Generated Active Oxygens in Linear IgA Bullous Dermatosis

Archives of Dermatology

Volumn 121, Issue 1, 1985, Pages 73-78

  Niwa, Yukie ^a   Sakane, Tsuyoshi ^a   Shingu, Masao ^b   Yanagida, Ichiro ^c   Komura, Jinro ^c   Miyachi, Yoshiki ^d  

^a SHIMANE UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KANSAI MEDICAL UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

BLOOD AND HEMOPOIETIC SYSTEM; CELL CULTURE; ENDOTHELIUM CELL; ETIOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; INJURY; LINEAR IMMUNOGLOBULIN A DISEASE; NEUTROPHIL; PRIORITY JOURNAL; TISSUE INJURY;

ADOLESCENT; ADULT; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; GLUCURONIDASE; HUMANS; HYDROGEN PEROXIDE; IMMUNOGLOBULIN A; MURAMIDASE; NEUTROPHILS; OXYGEN; SKIN DISEASES, VESICULOBULLOUS; ZYMOSAN;

EID: 84943448028     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1985.01660010077023     Document Type: Article

References (51)

1. Fridovich I: Oxygen radicals, hydrogen peroxide and oxygen toxicity, in Pryor WA (ed): Free Radicals in Biology. New York, Academic Press Inc, 1976, pp 239–251.
2. Salin ML, McCord JM: Free radicals and inflammation: Protection of phagocytosing leukocytes by superoxide dismutase. J Clin Invest 1975;56:1319–1323.
3. McCord JM, Fridovich I: The biology and pathology of oxygen radicals. Ann Intern Med 1978;89:122–127.
4. Niwa Y, Miyake S, Sakane T, et al: Autooxidative damage in Behçet's disease: Endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 1982;49:247–255.
5. Niwa Y, Sakane T, Shingu M, et al: Effect of stimulated neutrophils from the synovial fluid of patients with rheumatoid arthritis on lymphocytes: A possible role of increased oxygen radicals generated by the neutrophils. J Clin Immunol 1983;3:228–240.
6. Sacks T, Moldow CF, Craddock PR, et al: Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. J Clin Invest 1978;62:1161–1167.
7. Klebanoff SJ: Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin Hematol 1975;12:117–142.
8. Niwa Y, Sohmiya K: Enhanced neutrophilic functions in mucocutaneous lymph node syndrome (MCLS): With special reference to the possible role of increased oxygen intermediate generation in the pathogenesis of coronary thromboarteritis. J Pediatr 1984;104:56–60.
9. Boxer LA, Oliver JM, Spielberg SP, et al: Protection of granulocytes by vitamin E in glutathione synthetase deficiency. N Engl J Med 1979;301:901–905.
10. Spielberg SP, Boxer LA, Corash LM: Improved erythrocyte survival with high-dose vitamin E chronic hemolyzing G6PD and glutathione synthetase deficiencies. Ann Intern Med 1979;90:53–54.
11. Necheles TF, Maldonado N, Barquet-Chediak H: Homozygous erythrocyte glutathione-peroxidase deficiency: Clinical and biochemical studies. Blood 1969;33:164–169.
12. Skosey JL, Chow DC, Musinow S, et al: Effect of oxygen tension on human peripheral blood leukocytes. J Cell Biol 1981;88:358–363.
13. Metzger Z, Hoffeld JT, Oppenheim JJ: Macrophage-mediated suppression. J Immunol 1980;124:983–988.
14. Nishida H, Tanimoto K, Akaoka H: Effect of free radicals on the lymphocytes. Clin Immunol Immunopathol 1981;19:319–324.
15. Murray HW, Cohn ZA: Macrophage oxygen-department antimicrobial activity: I. Susceptibility of toxoplasma gondii to oxygen intermediates. J Exp Med 1979;150:938–949.
16. Murray HW, Juangbhnich CW, Nathan CF, et al: Macrophage oxygen-department antimicrobial activity: II. The role of oxygen intermediates. J Exp Med 1979;150:950–964.
17. Babior MB: Oxygen-dependent microbial killing by phagocytes. N Engl J Med 1978;298:659–668.
18. Takayama K, Noguchi T, Nakano M, et al: Reactivities of diphenylfuran (a singlet oxygen trap) with singlet oxygen and hydroxyl radical in aqueous systems. Biochem Biophys 1977;75:1052–1058.
19. Heikkila RE, Cabbat FS: Chemiluminescence from autooxidizing 6-hydroxydopamine: The involvement of activated forms of oxygen. Photochem Photobiol 1978;28:677–680.
20. Ushijima Y, Nakano M: No or little production of singlet molecular oxygen in HOCl or HOCl/H2O2. A model system for myeloperoxidase/H2O2/Cl-. Biochem Biophys 1980;93:1232–1237.
21. Chorzelski TP, Jablonska S, Beutner EH: Linear IgA bullous dermatosis, in Beutner EH, Chorzelski TP, Bean SF (eds): Immunopathology of the Skin, ed 2. New York, John Wiley & Sons Inc, 1979, pp 315–323.
22. Stendahl O, Molin L, Dahlgren C: The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. J Clin Invest 1978;62:214–220.
23. Cornbleet T: Sulfoxone (diasone) sodium for dermatitis herpetiformis. Arch Dermatol 1951;64:684–687.
24. Sheddon IB, Wilkinson DS: Subcorneal pustular dermatosis. Br J Dermatol 1956;68:385–394.
25. MacMillan AL, Champion RH: Generalized pustular psoriasis treated with dapsone. Br J Dermatol 1973;88:183–185.
26. Winkelmann RK, Ditto WB: Cutaneous and visceral symptoms of necrotizing or ‘allergic’ angiitis: A study of 38 cases. Medicine 1964;43:59–89.
27. Williams K, Capstick RB, Lewis DA, et al: Anti-inflammatory actions of dapsone and its related biochemistry. J Pharm Pharmacol 1976;28:555–558.
28. Ward M, McManns JPA: Dapsone in Crohn's disease. Lancet 1975;1:1236–1237.
29. Niwa Y, Sakane T, Miyachi Y: Dissociation of the inhibitory effect of dapsone on the generation of oxygen intermediates: In comparison with that of colchicine and various scavengers. Biochem Pharmacol 1984;35:2355–2360.
30. Miyachi Y, Niwa Y: Effect of potassium iodide, colchicine and dapsone on the generation of polymorphonuclear leukocytederived oxygen intermediates. Br J Dermatol 1982;107:209–214.
31. Ikai M, Imamura S: Pemphygus-like antibodies in dermatitis herpetiformis. Dermatologica 1976;152:302–308.
32. Miller DR, Kaplan HG: Decreased nitroblue tetrazolium dye reduction in the phagocytes of patients receiving prednisone. Pediatrics 1970;45:861–865.
33. Oyanagui Y: Inhibition of superoxide anion production in macrophages by anti-inflammatory drugs. Biochem Pharmacol 1976;25:1473–1480.
34. Skosey JL, Chow DC, Damgaard E, et al: Effect of cytochalasin B on the response of human polymorphonuclear leukocytes to zymosan. J Cell Biol 1973;57:237–240.
35. Skosey JL, Damgaard E, Chow DC, et al: Modification of zymosan-induced release of lysosomal enzymes from human polymorphonuclear leukocytes by cytochalasin B. J Cell Biol 1974;62:625–634.
36. Cohen PP: Suspending media for normal tissues, in Umbreit WW (ed): Monometric Techniques and Tissues Metabolism. Minneapolis, Burgess Publishing Co, 1957, pp 149–150.
37. Jaffe EA, Nachman RL, Becker CG, et al: Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973;52:2745–2756.
38. Maciag T, Hoover GA, Stemerman MB, et al: Serial propagation of human endothelial cells in vitro. J Cell Biol 1981;91:420–426.
39. Johnson AR, Erdos G: Metabolism of vasoactive peptides by human endothelial cells in culture. J Clin Invest 1977;59:684–695.
40. Hoyer LW, Santos RP, Hoyer JR: Antihemophilic factor antigen: Localization in endothelial cells by immunofluorescence microscopy. J Clin Invest 1976;52:2737–2744.
41. Jaffe EA: Endothelial cells and biology of the factor 8. N Engl J Med 1976;296:377–383.
42. Cochrane CG: Mechanisms involved in the deposition of immune complexes in tissues. J Exp Med 1971;134(suppl):75s–89s.
43. Kniker WT, Cochrane CG: The localization of immune complexes in experimental serum sickness: The role of vasoactive amines and hydrodynamic forces. J Exp Med 1968;127:119–136.
44. Weissman G, Znrier RB, Spieler PJ, et al: Mechanisms of lysosomal enzyme release from leukocytes exposed to immune complexes and other particles. J Exp Med 1971;134(suppl):149s–165s.
45. Michelson AM: Oxygen radicals, in Parnham MJ, Winkelmann J (eds): Agents and Actions. Basel, Switzerland, Birkhäuser Verlag, 1982, vol 11 (suppl), pp 179–201.
46. Emerit I, Michelson AM: Mechanism of photosensitivity in systemic lupus erythematosus patients. Proc Natl Acad Sci USA 1981;78:2537–2540.
47. Cochrane CG: Immunologic tissue injury mediated by neutrophilic leukocytes. Adv Immunol 1968;9:97–162.
48. Weissman G: Lysosomal mechanisms of tissue injury in arthritis. N Engl J Med 1972;286:141–147.
49. Janoff A: At least three human neutrophil lysosomal proteases are capable of degrading joint connective tissues. Ann NY Acad Sci 1975;256:402–408.
50. Cochrane CG, Unanue ER, Dixon FJ: A role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis. J Exp Med 1965;122:99–116.
51. Katz SI, Strober W: The pathogenesis of dermatitis herpetiformis. J Invest Dermatol 1978;70:63–75.